60,000 Shares in M3-Brigade Acquisition V Corp. $MBAV Purchased by DLD Asset Management LP

DLD Asset Management LP purchased a new position in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAVFree Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 60,000 shares of the company’s stock, valued at approximately $644,000.

Several other institutional investors also recently bought and sold shares of MBAV. Cantor Fitzgerald L. P. increased its position in shares of M3-Brigade Acquisition V by 4,940.8% in the fourth quarter. Cantor Fitzgerald L. P. now owns 7,779,865 shares of the company’s stock valued at $82,700,000 after buying an additional 7,625,527 shares in the last quarter. Anson Funds Management LP purchased a new position in shares of M3-Brigade Acquisition V during the 4th quarter valued at approximately $30,193,000. Meteora Capital LLC lifted its position in shares of M3-Brigade Acquisition V by 163.5% during the 4th quarter. Meteora Capital LLC now owns 3,889,052 shares of the company’s stock valued at $41,341,000 after buying an additional 2,413,251 shares in the last quarter. Pantera Capital Partners LP acquired a new stake in M3-Brigade Acquisition V in the 3rd quarter valued at $15,825,000. Finally, Polar Asset Management Partners Inc. grew its stake in M3-Brigade Acquisition V by 46.5% in the 4th quarter. Polar Asset Management Partners Inc. now owns 1,757,441 shares of the company’s stock valued at $18,682,000 after acquiring an additional 557,436 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on MBAV shares. Wall Street Zen raised shares of M3-Brigade Acquisition V to a “sell” rating in a report on Saturday, June 27th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of M3-Brigade Acquisition V in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, M3-Brigade Acquisition V currently has a consensus rating of “Sell”.

Get Our Latest Report on MBAV

M3-Brigade Acquisition V Stock Performance

Shares of M3-Brigade Acquisition V stock opened at $10.77 on Thursday. The stock’s 50 day simple moving average is $10.81 and its 200-day simple moving average is $10.76. M3-Brigade Acquisition V Corp. has a 1-year low of $9.10 and a 1-year high of $11.96.

M3-Brigade Acquisition V (NASDAQ:MBAVGet Free Report) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.05 EPS for the quarter.

M3-Brigade Acquisition V Company Profile

(Free Report)

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank?check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real?world data capabilities, combined with Brigade’s deep experience in credit and asset management.

See Also

Want to see what other hedge funds are holding MBAV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for M3-Brigade Acquisition V Corp. (NASDAQ:MBAVFree Report).

Institutional Ownership by Quarter for M3-Brigade Acquisition V (NASDAQ:MBAV)

Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.